"Glucose Tolerance Test" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg).
| Descriptor ID |
D005951
|
| MeSH Number(s) |
E01.370.225.124.100.355 E01.370.374.355 E05.200.124.100.355
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Glucose Tolerance Test".
Below are MeSH descriptors whose meaning is more specific than "Glucose Tolerance Test".
This graph shows the total number of publications written about "Glucose Tolerance Test" by people in this website by year, and whether "Glucose Tolerance Test" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 7 | 8 |
| 2003 | 1 | 4 | 5 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 5 | 5 |
| 2007 | 0 | 4 | 4 |
| 2008 | 2 | 6 | 8 |
| 2009 | 0 | 11 | 11 |
| 2010 | 0 | 6 | 6 |
| 2011 | 1 | 4 | 5 |
| 2012 | 0 | 8 | 8 |
| 2013 | 3 | 3 | 6 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 5 | 5 |
| 2016 | 1 | 7 | 8 |
| 2017 | 0 | 6 | 6 |
| 2018 | 2 | 6 | 8 |
| 2019 | 0 | 5 | 5 |
| 2020 | 2 | 6 | 8 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 3 | 3 |
| 2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glucose Tolerance Test" by people in Profiles.
-
Cystic fibrosis-related diabetes screening at a large pediatric center. Lab Med. 2024 Sep 04; 55(5):580-584.
-
Postpartum Glucose Monitoring in Pregnant Women with Gestational Diabetes Mellitus: A Dual Center Experience. Ann Clin Lab Sci. 2024 May; 54(3):331-334.
-
Is glucose pattern of OGTT associated with late-onset gestational diabetes and adverse pregnant outcomes? Ann Med. 2023; 55(2):2302516.
-
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 03; 72(3):294-304.
-
Persistence of ?-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening. Diabetes Care. 2022 12 01; 45(12):2982-2990.
-
Fasting Compared With Fed and Oral Intake Before the 1-Hour Oral Glucose Tolerance Test: A Randomized Controlled Trial. Obstet Gynecol. 2023 01 01; 141(1):126-133.
-
The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk. Diabetes Care. 2022 10 01; 45(10):2264-2270.
-
Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes. Diabetes Care. 2022 02 01; 45(2):311-318.
-
Endothelium-specific depletion of LRP1 improves glucose homeostasis through inducing osteocalcin. Nat Commun. 2021 09 06; 12(1):5296.
-
Glucose tolerance test with a single abnormal value in pregnancy and the risk of type-2 diabetes mellitus. Arch Gynecol Obstet. 2022 04; 305(4):869-875.